Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2 - PubMed (original) (raw)
Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2
J D Horton et al. J Clin Invest. 1998.
Abstract
We produced transgenic mice that express a dominant-positive truncated form of sterol regulatory element-binding protein-2 (SREBP-2) in liver and adipose tissue. The encoded protein lacks the membrane-binding and COOH-terminal regulatory domains, and it is therefore not susceptible to negative regulation by cholesterol. Livers from the transgenic mice showed increases in mRNAs encoding multiple enzymes of cholesterol biosynthesis, the LDL receptor, and fatty acid biosynthesis. The elevations in mRNA for 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) synthase and HMG CoA reductase were especially marked (13-fold and 75-fold, respectively). As a result, the transgenic livers showed a 28-fold increase in the rate of cholesterol synthesis and a lesser fourfold increase in fatty acid synthesis, as measured by intraperitoneal injection of [3H]water. These results contrast with previously reported effects of dominant-positive SREBP-1a, which activated fatty acid synthesis more than cholesterol synthesis. In adipose tissue of the SREBP-2 transgenics, the mRNAs for cholesterol biosynthetic enzymes were elevated, but the mRNAs for fatty acid biosynthetic enzymes were not. We conclude that SREBP-2 is a relatively selective activator of cholesterol synthesis, as opposed to fatty acid synthesis, in liver and adipose tissue of mice.
Similar articles
- Overproduction of cholesterol and fatty acids causes massive liver enlargement in transgenic mice expressing truncated SREBP-1a.
Shimano H, Horton JD, Hammer RE, Shimomura I, Brown MS, Goldstein JL. Shimano H, et al. J Clin Invest. 1996 Oct 1;98(7):1575-84. doi: 10.1172/JCI118951. J Clin Invest. 1996. PMID: 8833906 Free PMC article. - Elevated levels of SREBP-2 and cholesterol synthesis in livers of mice homozygous for a targeted disruption of the SREBP-1 gene.
Shimano H, Shimomura I, Hammer RE, Herz J, Goldstein JL, Brown MS, Horton JD. Shimano H, et al. J Clin Invest. 1997 Oct 15;100(8):2115-24. doi: 10.1172/JCI119746. J Clin Invest. 1997. PMID: 9329978 Free PMC article. - Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells.
Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, Goldstein JL. Shimano H, et al. J Clin Invest. 1997 Mar 1;99(5):846-54. doi: 10.1172/JCI119248. J Clin Invest. 1997. PMID: 9062341 Free PMC article. - Sterol regulatory element-binding protein family as global regulators of lipid synthetic genes in energy metabolism.
Shimano H. Shimano H. Vitam Horm. 2002;65:167-94. doi: 10.1016/s0083-6729(02)65064-2. Vitam Horm. 2002. PMID: 12481547 Review. - Sterol regulatory element-binding proteins: activators of cholesterol and fatty acid biosynthesis.
Horton JD, Shimomura I. Horton JD, et al. Curr Opin Lipidol. 1999 Apr;10(2):143-50. doi: 10.1097/00041433-199904000-00008. Curr Opin Lipidol. 1999. PMID: 10327282 Review.
Cited by
- Metabolic reprogramming of hypoxic tumor-associated macrophages through CSF-1R targeting favors treatment efficiency in colorectal cancers.
Gharzeddine K, Gonzalez Prieto C, Malier M, Hennot C, Grespan R, Yamaryo-Botté Y, Botté CY, Thomas F, Laverriere MH, Girard E, Roth G, Millet A. Gharzeddine K, et al. J Immunother Cancer. 2024 Sep 24;12(9):e009602. doi: 10.1136/jitc-2024-009602. J Immunother Cancer. 2024. PMID: 39317456 Free PMC article. - N-SREBP2 Provides a Mechanism for Dynamic Control of Cellular Cholesterol Homeostasis.
Ozkan-Nikitaras T, Grzesik DJ, Romano LEL, Chapple JP, King PJ, Shoulders CC. Ozkan-Nikitaras T, et al. Cells. 2024 Jul 25;13(15):1255. doi: 10.3390/cells13151255. Cells. 2024. PMID: 39120286 Free PMC article. - SREBPs as the potential target for solving the polypharmacy dilemma.
Wang X, Chen Y, Meng H, Meng F. Wang X, et al. Front Physiol. 2024 Jan 10;14:1272540. doi: 10.3389/fphys.2023.1272540. eCollection 2023. Front Physiol. 2024. PMID: 38269061 Free PMC article. Review. - The Role of SCAP/SREBP as Central Regulators of Lipid Metabolism in Hepatic Steatosis.
Chandrasekaran P, Weiskirchen R. Chandrasekaran P, et al. Int J Mol Sci. 2024 Jan 16;25(2):1109. doi: 10.3390/ijms25021109. Int J Mol Sci. 2024. PMID: 38256181 Free PMC article. Review. - Lipid Metabolism Regulators Are the Possible Determinant for Characteristics of Myopic Human Scleral Stroma Fibroblasts (HSSFs).
Ohguro H, Umetsu A, Sato T, Furuhashi M, Watanabe M. Ohguro H, et al. Int J Mol Sci. 2023 Dec 29;25(1):501. doi: 10.3390/ijms25010501. Int J Mol Sci. 2023. PMID: 38203671 Free PMC article.
References
- Anal Biochem. 1987 Apr;162(1):156-9 - PubMed
- Lipids. 1988 Dec;23(12):1146-9 - PubMed
- Mol Cell Biol. 1992 Mar;12(3):1007-20 - PubMed
- Mol Cell Biol. 1993 Aug;13(8):4753-9 - PubMed
- Nature. 1993 Sep 2;365(6441):65-9 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials